Fiscal impact reports (FIRs) are prepared by the Legislative Finance Committee (LFC) for standing finance
committees of the NM Legislature. The LFC does not assume responsibility for the accuracy of these reports
if they are used for other purposes.
Current FIRs (in HTML & Adobe PDF formats) are a vailable on the NM Legislative Website (legis.state.nm.us).
Adobe PDF versions include all attachments, whereas HTML versions may not. Previously issued FIRs and
attachments may be obtained from the LFC in Suite 101 of the State Capitol Building North.
F I S C A L I M P A C T R E P O R T
SPONSOR Snyder
DATE TYPED 02/26/05 HB
SHORT TITLE Prescription Drug Reimbursement Tax Credit
SB 552
ANALYST Padilla-Jackson
REVENUE
Estimated Revenue
Subsequent
Years Impact
Recurring
or Non-Rec
Fund
Affected
FY05
FY06
($26,000.0)* ($53,000.0)
Recurring
General Fund
(Parenthesis ( ) Indicate Revenue Decreases)
*The FY2005 impact is assumed to be approximately 50 percent of the full-year fiscal impact.
SOURCES OF INFORMATION
LFC Files
Responses Received From
Taxation and Revenue Department (TRD)
Aging and Long Term Care Department (ALTSD)
SUMMARY
Synopsis of Bill
Senate Bill 552 would provide a new personal income tax credit for a resident that is 65 years or
older, for un-reimbursed prescription drug costs. The tax credit would be in amount not to ex-
ceed seventy-five percent of the prescription drug expenditures. The credit is refundable, so that
if the credit exceeds the taxpayer’s liability, the excess shall be refunded to the taxpayer.
Credits would not be allowed for those expenditures included in a taxpayer’s itemized deduc-
tions. Additionally, a claim for the credit cannot be filed by a resident who was an inmate of a
public institution for more than six months of the taxable year or who was not in New Mexico
for at leas six months of the taxable year.
The provisions of this bill are applicable to tax years beginning on or after January 1, 2005.
pg_0002
Senate Bill 552 -- Page 2
FISCAL IMPLICATIONS
The total fiscal impact, as provided by TRD, is -$53 million to the general fund in FY06. TRD’s
estimate assumes that there are 212,225 New Mexicans over the age of 65, 205,647 of whom do
not reside in institutions and 72 percent who do not itemize deductions. These assumptions im-
ply approximately 148,000 in potential credits, at an average claim of $356.00 (75% of the aver-
age prescription drug cost of $475), would be expected to generate about $53 million (148,000
times $356.00).
ADMINISTRATIVE IMPLICATIONS
The bill would reportedly have a minor administrative impact on TRD, as the provisions of this
bill could be performed with existing resources.
OPJ/lg